Hallucinogens and Their Therapeutic Use: A Literature Review.
Journal of psychiatric practice September 1, 2019 Matthew J Begola, Jason E Schillerstrom 20 citations
A review of the literature on hallucinogens for psychiatric disorders found that substances such as ayahuasca, ibogaine, ketamine, LSD, MDMA, and psilocybin have been studied for conditions including depression, autism, and especially substance use disorders. Most studies reported significant symptom improvement, but the review could not draw definitive conclusions because the research suffered from small sample sizes, inconsistent measures, and poor study design. The authors call for well-designed, standardized studies to properly assess risks and benefits.